Search

everythinglearnresearchcommunity

for

Search:↓

Triamcinolone acetonide is more effective than cryotherapy for hair regrowth in alopecia areata but has different side effects.

Homeopathy improved hair growth, gut health, and emotions in a boy with Down syndrome.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

Higher air pollution increases the risk of alopecia areata.

Children with alopecia areata have lower BDNF levels, linked to worse symptoms and quality of life.

People with alopecia areata have a higher risk of heart disease.

Men with alopecia areata tend to have larger limb and trunk circumferences than healthy men.

Significant, lasting hair regrowth is needed to improve how patients with Alopecia Areata feel about their condition.

Patients with Alopecia Areata are willing to trade life duration for better quality of life.

Alopecia areata patients may have higher T3 and cortisol levels, suggesting a hormonal link.

Technology can improve sexual dysfunction in chronic disease patients but faces challenges like cost and accessibility.

Calcipotriol's effectiveness for treating alopecia areata is unclear and needs more research.

Mothers with alopecia areata have a higher risk of adverse birth outcomes.

Over half of alopecia areata patients in Tunisia experience depression, highlighting the need for psychological support.

Darker hair colors may increase the risk of alopecia areata, while lighter hair colors may decrease it.

Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Upadacitinib may effectively treat alopecia areata without side effects.

Atopic dermatitis in kids with alopecia areata can predict poor response to topical immunotherapy.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Rhupus is a complex syndrome that is hard to diagnose due to unclear clinical criteria.

COVID-19 vaccination does not significantly increase the risk of developing alopecia areata.

SLE and DM can coexist but are rare and need careful evaluation.

Clobetasol propionate 0.05% is more effective for hair re-growth in alopecia areata than tacrolimus 0.1%.

Elderly patients frequently suffer from skin conditions, especially inflammatory ones, highlighting the need for better healthcare.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

Early diagnosis of GLPLS is crucial to prevent complications, but scarring alopecia is irreversible.

A rare scalp condition caused scarring hair loss in a woman, improved slightly with treatment.